NEW VISCOSUPPLEMENTS
HAPPYMINI® in the treatment of Temporo-Mandibular Osteoarthritis

HAPPYMINI® in the treatment of Temporo-Mandibular Osteoarthritis

  This prospective pilot study was conducted to show the Safety & Efficacy of a Single Injection of Mannitol-modified Cross-Linked Hyaluronic Acid (HAppyMini®) in the treatment of the Temporo-Mandibular Osteoartritis.   Results  at D180 : Treatment was efficient or very efficient for 94% of the patients Long lasting improvment of the inter-incisal distance  2/3 of patients reduced their painkillers / NSAIDs intake   UNIQUE COMBINATION...
Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked HA in Patients with Trapeziometacarpal OA.

Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked HA in Patients with Trapeziometacarpal OA.

    Like every year since 2012, LABRHA attended the EULAR Annual Meeting which took place in Amsterdam from the 13th  to the 16th of June 2018.      During the scientific session on « OSTEOARTHRITIS and microcrystalline disease », Dr Thierry CONROZIER (France) presented results of the INSTINCT Study: influence of the radiological grade on the efficacy of an intra-articular injection of...
4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

2017 was no exception and after 3 successful editions, LABRHA organised last 07th and 08th of September 2017  its 4th LABRHA European Board on Viscosupplementation. 8 members of the EUROVISCO group participated this year. The group welcomed for this edition a new participant from Turkey, Prof. Demirhan Diracoglu, Physical Medicine and Rehabilitation specialist at the...
Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of Single Intra-Articular Injection of a Cross-Linked Hyaluronic Acid/Mannitol Formulation [Happycross®] in knee Osteoarthritis Results of a Prospective Observational Study in Daily Practice Conditions. Monet M, Bozgan AM, Conrozier T. Ortho & Rheum Open Access 2017; 5(3): 555664. DOI: 10.19080/OROAJ.2017.05.555664. . This study has been conducted to assess in daily practice conditions,...
Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis. Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).R. Raman, Y. Henrotin, X. Chevalier, A. Migliore, J. Jerosch, J. Montfort, H. Bard, D. Baron, P. Richette, T. Conrozier. Cartilage. February-01-2017. Doi: 10.1177/1947603517693043 The paper « Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering...